Seek Returns logo

HIMS vs. ORCL: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at HIMS and ORCL, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolHIMSORCL
Company NameHims & Hers Health, Inc.Oracle Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS IndustryHealth Care Providers & ServicesSoftware
Market Capitalization13.10 billion USD823.91 billion USD
ExchangeNYSENYSE
Listing DateSeptember 13, 2019March 12, 1986
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of HIMS and ORCL by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

HIMS vs. ORCL: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolHIMSORCL
5-Day Price Return6.52%-8.82%
13-Week Price Return13.78%28.64%
26-Week Price Return70.02%90.28%
52-Week Price Return219.19%66.67%
Month-to-Date Return33.93%24.37%
Year-to-Date Return134.57%68.77%
10-Day Avg. Volume26.13M32.16M
3-Month Avg. Volume35.44M18.59M
3-Month Volatility77.74%82.45%
Beta2.251.52

Profitability

Return on Equity (TTM)

HIMS

38.17%

Health Care Providers & Services Industry

Max
24.86%
Q3
15.79%
Median
8.56%
Q1
5.75%
Min
-1.64%

HIMS’s Return on Equity of 38.17% is exceptionally high, placing it well beyond the typical range for the Health Care Providers & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

ORCL

66.28%

Software Industry

Max
66.28%
Q3
21.28%
Median
9.33%
Q1
-8.77%
Min
-48.16%

In the upper quartile for the Software industry, ORCL’s Return on Equity of 66.28% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

HIMS vs. ORCL: A comparison of their Return on Equity (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Net Profit Margin (TTM)

HIMS

9.62%

Health Care Providers & Services Industry

Max
11.56%
Q3
5.45%
Median
2.83%
Q1
1.13%
Min
-1.71%

A Net Profit Margin of 9.62% places HIMS in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.

ORCL

21.08%

Software Industry

Max
51.92%
Q3
19.23%
Median
6.98%
Q1
-7.14%
Min
-41.00%

A Net Profit Margin of 21.08% places ORCL in the upper quartile for the Software industry, signifying strong profitability and more effective cost management than most of its peers.

HIMS vs. ORCL: A comparison of their Net Profit Margin (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Operating Profit Margin (TTM)

HIMS

6.24%

Health Care Providers & Services Industry

Max
19.08%
Q3
9.66%
Median
4.77%
Q1
2.46%
Min
-0.83%

HIMS’s Operating Profit Margin of 6.24% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

ORCL

30.44%

Software Industry

Max
60.40%
Q3
21.25%
Median
9.90%
Q1
-4.97%
Min
-43.50%

An Operating Profit Margin of 30.44% places ORCL in the upper quartile for the Software industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

HIMS vs. ORCL: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Profitability at a Glance

SymbolHIMSORCL
Return on Equity (TTM)38.17%66.28%
Return on Assets (TTM)18.98%7.56%
Net Profit Margin (TTM)9.62%21.08%
Operating Profit Margin (TTM)6.24%30.44%
Gross Profit Margin (TTM)76.20%69.66%

Financial Strength

Current Ratio (MRQ)

HIMS

4.98

Health Care Providers & Services Industry

Max
2.00
Q3
1.51
Median
1.29
Q1
0.92
Min
0.14

HIMS’s Current Ratio of 4.98 is exceptionally high, placing it well outside the typical range for the Health Care Providers & Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.

ORCL

0.62

Software Industry

Max
4.29
Q3
2.37
Median
1.40
Q1
1.03
Min
0.25

ORCL’s Current Ratio of 0.62 falls into the lower quartile for the Software industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

HIMS vs. ORCL: A comparison of their Current Ratio (MRQ) against their respective Health Care Providers & Services and Software industry benchmarks.

Debt-to-Equity Ratio (MRQ)

HIMS

1.72

Health Care Providers & Services Industry

Max
2.29
Q3
1.24
Median
0.74
Q1
0.50
Min
0.00

HIMS’s leverage is in the upper quartile of the Health Care Providers & Services industry, with a Debt-to-Equity Ratio of 1.72. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

ORCL

3.78

Software Industry

Max
2.16
Q3
0.86
Median
0.31
Q1
0.00
Min
0.00

With a Debt-to-Equity Ratio of 3.78, ORCL operates with exceptionally high leverage compared to the Software industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

HIMS vs. ORCL: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Providers & Services and Software industry benchmarks.

Interest Coverage Ratio (TTM)

HIMS

--

Health Care Providers & Services Industry

Max
14.47
Q3
7.50
Median
4.52
Q1
2.12
Min
-4.44

Interest Coverage Ratio data for HIMS is currently unavailable.

ORCL

4.92

Software Industry

Max
89.65
Q3
32.64
Median
1.00
Q1
-9.84
Min
-71.23

ORCL’s Interest Coverage Ratio of 4.92 is positioned comfortably within the norm for the Software industry, indicating a standard and healthy capacity to cover its interest payments.

HIMS vs. ORCL: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Financial Strength at a Glance

SymbolHIMSORCL
Current Ratio (MRQ)4.980.62
Quick Ratio (MRQ)4.300.50
Debt-to-Equity Ratio (MRQ)1.723.78
Interest Coverage Ratio (TTM)--4.92

Growth

Revenue Growth

HIMS vs. ORCL: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

HIMS vs. ORCL: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

HIMS

0.00%

Health Care Providers & Services Industry

Max
5.93%
Q3
2.59%
Median
1.35%
Q1
0.00%
Min
0.00%

HIMS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ORCL

0.63%

Software Industry

Max
0.22%
Q3
0.11%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL’s Dividend Yield of 0.63% is exceptionally high, placing it well above the typical range for the Software industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.

HIMS vs. ORCL: A comparison of their Dividend Yield (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Dividend Payout Ratio (TTM)

HIMS

0.00%

Health Care Providers & Services Industry

Max
185.33%
Q3
74.82%
Median
36.00%
Q1
0.00%
Min
0.00%

HIMS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ORCL

40.62%

Software Industry

Max
3.29%
Q3
2.41%
Median
0.00%
Q1
0.00%
Min
0.00%

At 40.62%, ORCL’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Software industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.

HIMS vs. ORCL: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Dividend at a Glance

SymbolHIMSORCL
Dividend Yield (TTM)0.00%0.63%
Dividend Payout Ratio (TTM)0.00%40.62%

Valuation

Price-to-Earnings Ratio (TTM)

HIMS

65.74

Health Care Providers & Services Industry

Max
40.02
Q3
29.75
Median
21.09
Q1
14.18
Min
7.05

At 65.74, HIMS’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Providers & Services industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

ORCL

64.02

Software Industry

Max
145.74
Q3
94.88
Median
45.35
Q1
26.66
Min
8.80

ORCL’s P/E Ratio of 64.02 is within the middle range for the Software industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

HIMS vs. ORCL: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Price-to-Sales Ratio (TTM)

HIMS

6.32

Health Care Providers & Services Industry

Max
3.15
Q3
1.87
Median
0.74
Q1
0.27
Min
0.09

With a P/S Ratio of 6.32, HIMS trades at a valuation that eclipses even the highest in the Health Care Providers & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ORCL

13.50

Software Industry

Max
25.67
Q3
13.68
Median
8.28
Q1
4.95
Min
0.90

ORCL’s P/S Ratio of 13.50 aligns with the market consensus for the Software industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

HIMS vs. ORCL: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Providers & Services and Software industry benchmarks.

Price-to-Book Ratio (MRQ)

HIMS

19.83

Health Care Providers & Services Industry

Max
7.33
Q3
4.45
Median
2.52
Q1
1.15
Min
0.66

At 19.83, HIMS’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ORCL

26.30

Software Industry

Max
30.67
Q3
14.92
Median
8.52
Q1
3.89
Min
0.38

ORCL’s P/B Ratio of 26.30 is in the upper tier for the Software industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

HIMS vs. ORCL: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Providers & Services and Software industry benchmarks.

Valuation at a Glance

SymbolHIMSORCL
Price-to-Earnings Ratio (TTM)65.7464.02
Price-to-Sales Ratio (TTM)6.3213.50
Price-to-Book Ratio (MRQ)19.8326.30
Price-to-Free Cash Flow Ratio (TTM)53.8193.95